Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study.
about
Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Evaluation of the Efficacy and ...... -Blind, Non-Inferiority Study.
@en
Evaluation of the Efficacy and ...... -Blind, Non-Inferiority Study.
@nl
type
label
Evaluation of the Efficacy and ...... -Blind, Non-Inferiority Study.
@en
Evaluation of the Efficacy and ...... -Blind, Non-Inferiority Study.
@nl
prefLabel
Evaluation of the Efficacy and ...... -Blind, Non-Inferiority Study.
@en
Evaluation of the Efficacy and ...... -Blind, Non-Inferiority Study.
@nl
P2093
P2860
P50
P1476
Evaluation of the Efficacy and ...... e-Blind, Non-Inferiority Study
@en
P2093
Dae Hwan Kang
Jin Seok Jang
Sang Yong Seol
P2860
P304
P356
10.3346/JKMS.2017.32.11.1807
P50
P577
2017-11-01T00:00:00Z